Squarepoint’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.1M Buy
483,937
+320,124
+195% +$2.71M ﹤0.01% 867
2025
Q1
$1.32M Buy
163,813
+47,216
+40% +$380K ﹤0.01% 1371
2024
Q4
$1.05M Buy
+116,597
New +$1.05M ﹤0.01% 1504
2023
Q3
Sell
-22,941
Closed -$222K 2451
2023
Q2
$222K Buy
22,941
+3,545
+18% +$34.3K ﹤0.01% 2018
2023
Q1
$213K Sell
19,396
-20,267
-51% -$222K ﹤0.01% 1842
2022
Q4
$171K Buy
39,663
+4,667
+13% +$20.2K ﹤0.01% 1932
2022
Q3
$263K Buy
+34,996
New +$263K ﹤0.01% 1685
2022
Q2
Sell
-227,114
Closed -$2.81M 2117
2022
Q1
$2.81M Buy
227,114
+134,933
+146% +$1.67M 0.01% 655
2021
Q4
$2.11M Buy
92,181
+46,428
+101% +$1.06M 0.01% 842
2021
Q3
$1.01M Buy
+45,753
New +$1.01M ﹤0.01% 1072
2020
Q2
Sell
-35,084
Closed -$509K 2145
2020
Q1
$509K Buy
35,084
+5,989
+21% +$86.9K 0.01% 1026
2019
Q4
$589K Buy
+29,095
New +$589K ﹤0.01% 1632